Zecyte 250mg Tablet
Product introduction
Zecyte 250mg Tablet should be taken on an empty stomach, either one hour before or at least two hours after a meal. Taking it with food may increase the blood levels of Zecyte 250mg Tablet, which may cause side effects. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.
The most common side effects of Zecyte 250mg Tablet include vomiting, decreased potassium level in blood, edema (swelling), decreased white blood cell count, and fatigue. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Other than this, the yellowing of the skin, loss of appetite, shortness of breath, dark urine, and nausea can happen, which indicate some liver problems. Your doctor might check you for liver function, blood pressure, and the level of potassium in your blood.
Before taking Zecyte 250mg Tablet, tell your doctor if you have high blood pressure, heart problems, liver or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medication, so let your doctor know about all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It may harm your baby. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You may be asked to undergo regular monitoring of your blood glucose level while on treatment.
Uses of Zecyte Tablet
- Sickle cell anemia
- Prostate cancer
- Blood cancer (Acute lymphocytic leukemia)
- Soft tissue sarcoma
- Hodgkin’s disease
Side effects of Zecyte Tablet
Common side effects of Zecyte
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
- Nausea
- Hot flashes
- Headache
- Increased glucose level in blood
How to use Zecyte Tablet
How Zecyte Tablet works
Safety advice
What if you forget to take Zecyte Tablet?
All substitutes
Quick tips
- Zecyte 250mg Tablet is usually taken with another medicine called prednisolone to reduce unwanted side effects.
- It should be taken on an empty stomach, either one hour before or at least two hours after a meal.
- Always use effective birth control measures to prevent pregnancy while taking this medicine.
- Your doctor may regularly monitor your liver function, blood pressure, and the level of potassium in your blood while you are having treatment with this medicine.
Fact Box
Interaction with drugs
Patient concerns
User feedback
FAQs
How to take Zecyte 250mg Tablet?
Can Zecyte 250mg Tablet cure prostate cancer?
Is Zecyte 250mg Tablet a chemotherapy drug?
Why do I need to take prednisolone with Zecyte 250mg Tablet?
Does Zecyte 250mg Tablet affect liver?
How frequently should the liver investigations be done?
Related ayurvedic ingredients
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 4-5.